0000000000140967

AUTHOR

Rapaccini G. L.

showing 2 related works from this author

Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma.

2014

Lead-time is the time by which diagnosis is anticipated by screening/surveillance with respect to the symptomatic detection of a disease. Any screening program, including surveillance for hepatocellular carcinoma (HCC), is subject to lead-time bias. Data regarding lead-time for HCC are lacking. Aims of the present study were to calculate lead-time and to assess its impact on the benefit obtainable from the surveillance of cirrhotic patients. Background & Aims: Lead-time is the time by which diagnosis is anticipated by screening/surveillance with respect to the symptomatic detection of a disease. Any screening program, including surveillance for hepatocellular carcinoma (HCC), is subject to …

Malemedicine.medical_specialtyPediatricsCarcinoma HepatocellularTime FactorsHepatocellular carcinomaSettore MED/12 - GASTROENTEROLOGIADiseaseGastroenterologyBiasInternal medicineOverall survivalmedicineHumansEarly Detection of CancerAgedEstimationSurveillanceHepatologybusiness.industryLiver Neoplasmsmedicine.diseasedigestive system diseasesLead time biasCirrhosisHepatocellular carcinomaFemalebusinessLead-time biasFollow-Up Studies
researchProduct

SIUMB recommendations for focal pancreatic lesions

2020

AbstractContrast-enhanced ultrasonography (CEUS) is increasingly being performed in Italy and Europe, particularly in the field of hepato-gastroenterology. Initially, it was mainly carried out to characterize focal hepatic lesions, but, since then, numerous studies have demonstrated its efficacy in the differential diagnosis of focal pancreatic pathologies (D’Onofrio et al. in Expert Rev Med Devices 7(2):257–273, 2010; Vidili et al. in J Ultrasound 22(1):41–51, 2019). The purpose of this paper is to provide Italian Medical Doctors with recommendations and thereby practical guidelines on the management of these patients. The present paper reports the final conclusions reached by the SIUMB gu…

Image-Guided Biopsymedicine.medical_specialtyPercutaneousContrast Media030218 nuclear medicine & medical imagingDiagnosis Differential03 medical and health sciencesPancreatic cystic lesion0302 clinical medicinePancreatic cancerCEUS; Contrast-enhanced ultrasound; Pancreas; Pancreatic adenocarcinoma; Pancreatic biopsy; Pancreatic cancer; Pancreatic cancer; Pancreatic cystic lesions; Ultrasound; Diagnosis Differential; Humans; Image-Guided Biopsy; Pancreatic Cyst; Pancreatic Neoplasms; Ultrasonography; Contrast MediaDiagnosisCEUS Ultrasound Contrast-enhanced ultrasound Pancreas Pancreatic adenocarcinoma Pancreatic cystic lesions Pancreatic biopsy Pancreatic cancerUltrasoundInternal MedicinemedicineHumansPancreaRadiology Nuclear Medicine and imagingPancreatic biopsyPancreasCEUS; Contrast-enhanced ultrasound; Pancreas; Pancreatic adenocarcinoma; Pancreatic biopsy; Pancreatic cancer; Pancreatic cancer; Pancreatic cystic lesions; UltrasoundUltrasonography030219 obstetrics & reproductive medicinebusiness.industryGeneral surgeryPancreatic biopsyGeneral MedicineGuidelinePancreatic cancermedicine.diseasePancreatic Neoplasmsmedicine.anatomical_structureDifferentialCEUSOriginal ArticleCEUS; Contrast-enhanced ultrasound; Pancreas; Pancreatic adenocarcinoma; Pancreatic biopsy; Pancreatic cancer; Pancreatic cystic lesions; UltrasoundUltrasonographyDifferential diagnosisPancreatic CystbusinessPancreasPancreatic adenocarcinomaContrast-enhanced ultrasoundContrast-enhanced ultrasoundPancreatic cystic lesions
researchProduct